Wolves living inside the Chernobyl Exclusion Zone show genetic and immune-system signals that researchers say may be linked ...

Given the success of the <a href=" edition of Altered Metabolic Traits in Gastrointestinal Tract Cancers, we are pleased to announce the Volume II.<br/><br/>The field of gastrointestinal (GI) tract ...

New data from the MEL-SELF trial show gaps in melanoma self-surveillance confidence, highlighting opportunities to improve ...

Look around your home. A food wrapper, a shampoo bottle, a couch cushion and many other items very likely contain synthetic chemicals that were never tested for long-term safety before reaching store ...

As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and ...

Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancin ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...

Patients who received narrative-based palliative care also reported better quality of life, improved sleep quality, and greater acceptance of death compared with patients receiving routine care. These ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...

Relmada Therapeutics(NASDAQ:RLMD) reported that clinical progress for NDV01 includes durable, high 12-month complete response rates in both broad and BCG-unresponsive NMIBC populations, with favorable ...

Dr. Fizazi began by revisiting the role of docetaxel in the mHSPC setting, emphasizing that treatment benefit varies ...